Evaluating Alternative Aftercare Models for Ex-offenders

January 11, 2017 updated by: National Institute on Drug Abuse (NIDA)
This study is examining the relative effects of alternative aftercare models for ex-offenders who are recovering from substance abuse/addiction. The study is a longitudinal, randomized field trial that assigns participants to one of three conditions: Oxford House, a professionally-run residential treatment facility, or a control condition that involves usual aftercare chosen by participants (which may include no treatment at all). Oxford Houses are self-run residential recovery homes based on the premise of mutual support. These homes do not involve professional treatment staff and the expenses (e.g. rent, utilities) are paid for by the residents. The hypothesis of this study is that Oxford House participants will have as good or better outcomes in terms of substance recovery, recidivism, and health in comparison to the participants who were assigned to the residential treatment facility, and better outcomes in comparison to the control group. In addition, the cost to government/tax payers will be substantially lower given that participants pay their own way.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

270

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Illinois
      • Chicago, Illinois, United States, 60614
        • DePaul University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • released from prison/jail in last 24 months
  • recovering from alcohol or drug dependence

Exclusion Criteria:

  • convicted of violent crime such as murder, aggravated assault
  • currently using alcohol or drugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Safe Haven
participants assigned to the Safe haven condition and agree to move into the A Safe Haven residential treatment facility
Behavioral: Safe Haven
professionally-staffed treatment facility
Experimental: Usual aftercare
participants assigned to the control condition, and may or may not seek treatment on their own
Behavioral: Usual aftercare
control group - participants may or may not seek treatment on their own
Experimental: Oxford House
participants who were assigned to the Oxford House condition and agree to move into an Oxford House
Behavioral: Oxford House
community-based recovery home for participants recovering from substance dependency

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relapse/recovery - drug test and self report of alcohol use
Time Frame: last data collection point (wave 5, 2 years after recruitment)
An assessment of each participant's drug/alcohol use as determined by a urine test and report of alcohol use
last data collection point (wave 5, 2 years after recruitment)
recidivism
Time Frame: last data collection point (wave 5, 2 years after recruitment)
whether or not the participant has been re-incarcerated, as indicated by Illinois Department of Corrections data base
last data collection point (wave 5, 2 years after recruitment)
health
Time Frame: last data collection point (wave 5, 2 years after recruitment)
participant health, such as hospitalization and other indicators as measured by the Addiction Severity Index (ASI) - Light. also measures substance use, employment, legal system involvement, family and social life, psychiatric status.
last data collection point (wave 5, 2 years after recruitment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Drug Taking Confidence Questionnaire (DTCQ)
Time Frame: every 6 months for 2 years
confidence to avoid using drugs and alcohol in various situations;
every 6 months for 2 years
Risk Behavior Survey
Time Frame: every 6 months for 2 years
recent substance use and sexual behaviors
every 6 months for 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Leonard Jason, PhD, DePaul University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2006

Primary Completion (Actual)

June 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

April 25, 2012

First Submitted That Met QC Criteria

April 26, 2012

First Posted (Estimate)

April 27, 2012

Study Record Updates

Last Update Posted (Estimate)

January 12, 2017

Last Update Submitted That Met QC Criteria

January 11, 2017

Last Verified

September 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OHEO1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Drug/Substance Abuse/Addiction

Clinical Trials on Safe Haven

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe